Assessing immunologic risk factors in transplantation

Mary Carmelle Philogene, Andrea A. Zachary

Research output: Contribution to journalArticle

Abstract

The innate and adaptive immune systems, together, represent the largest impediment to good and long-lasting graft function. Although improved immunosuppressive agents and expanded and enhanced diagnostic tools have led to better prevention and treatment of acute rejection, chronic rejection remains a serious threat to long-term graft survival. Immunologic heterogeneity among patients, variability in treatment protocols and unforeseen events following transplantation translate into different levels of risk among patients. While one cannot predict with certainty the short-and long-term outcomes of a particular transplant, it is possible to identify immunologic risk factors that can affect outcome.

Original languageEnglish (US)
Pages (from-to)773-779
Number of pages7
JournalExpert Review of Clinical Immunology
Volume9
Issue number8
DOIs
StatePublished - Aug 2013

Fingerprint

Immunologic Factors
Transplantation
Transplants
Graft Survival
Immunosuppressive Agents
Clinical Protocols
Immune System
Therapeutics

Keywords

  • anamnestic response
  • antibody-mediated rejection
  • chronic rejection
  • DSA
  • graft survival
  • noninherited maternal antigen proinflammatory cytokines
  • risk assessment
  • sensitization

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Assessing immunologic risk factors in transplantation. / Philogene, Mary Carmelle; Zachary, Andrea A.

In: Expert Review of Clinical Immunology, Vol. 9, No. 8, 08.2013, p. 773-779.

Research output: Contribution to journalArticle

@article{56f7301404a24cb3aea825468810098f,
title = "Assessing immunologic risk factors in transplantation",
abstract = "The innate and adaptive immune systems, together, represent the largest impediment to good and long-lasting graft function. Although improved immunosuppressive agents and expanded and enhanced diagnostic tools have led to better prevention and treatment of acute rejection, chronic rejection remains a serious threat to long-term graft survival. Immunologic heterogeneity among patients, variability in treatment protocols and unforeseen events following transplantation translate into different levels of risk among patients. While one cannot predict with certainty the short-and long-term outcomes of a particular transplant, it is possible to identify immunologic risk factors that can affect outcome.",
keywords = "anamnestic response, antibody-mediated rejection, chronic rejection, DSA, graft survival, noninherited maternal antigen proinflammatory cytokines, risk assessment, sensitization",
author = "Philogene, {Mary Carmelle} and Zachary, {Andrea A.}",
year = "2013",
month = "8",
doi = "10.1586/1744666X.2013.814413",
language = "English (US)",
volume = "9",
pages = "773--779",
journal = "Expert Review of Clinical Immunology",
issn = "1744-666X",
publisher = "Expert Reviews Ltd.",
number = "8",

}

TY - JOUR

T1 - Assessing immunologic risk factors in transplantation

AU - Philogene, Mary Carmelle

AU - Zachary, Andrea A.

PY - 2013/8

Y1 - 2013/8

N2 - The innate and adaptive immune systems, together, represent the largest impediment to good and long-lasting graft function. Although improved immunosuppressive agents and expanded and enhanced diagnostic tools have led to better prevention and treatment of acute rejection, chronic rejection remains a serious threat to long-term graft survival. Immunologic heterogeneity among patients, variability in treatment protocols and unforeseen events following transplantation translate into different levels of risk among patients. While one cannot predict with certainty the short-and long-term outcomes of a particular transplant, it is possible to identify immunologic risk factors that can affect outcome.

AB - The innate and adaptive immune systems, together, represent the largest impediment to good and long-lasting graft function. Although improved immunosuppressive agents and expanded and enhanced diagnostic tools have led to better prevention and treatment of acute rejection, chronic rejection remains a serious threat to long-term graft survival. Immunologic heterogeneity among patients, variability in treatment protocols and unforeseen events following transplantation translate into different levels of risk among patients. While one cannot predict with certainty the short-and long-term outcomes of a particular transplant, it is possible to identify immunologic risk factors that can affect outcome.

KW - anamnestic response

KW - antibody-mediated rejection

KW - chronic rejection

KW - DSA

KW - graft survival

KW - noninherited maternal antigen proinflammatory cytokines

KW - risk assessment

KW - sensitization

UR - http://www.scopus.com/inward/record.url?scp=84887834483&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887834483&partnerID=8YFLogxK

U2 - 10.1586/1744666X.2013.814413

DO - 10.1586/1744666X.2013.814413

M3 - Article

C2 - 23971755

AN - SCOPUS:84887834483

VL - 9

SP - 773

EP - 779

JO - Expert Review of Clinical Immunology

JF - Expert Review of Clinical Immunology

SN - 1744-666X

IS - 8

ER -